HARRIS C MARTIN 4

What Happened
Harris C. Martin, a director of Thermo Fisher Scientific (TMO), received an award of 499 shares on May 20, 2026. The Form 4 reports the acquisition as an award/grant (code A) with a reported price of $0.00, meaning no cash was paid in this transaction.

Key Details

• Transaction date: 2026-05-20; filing date: 2026-05-22 (filed 2 days after the transaction).
• Transaction type/code: Award/other acquisition (A).
• Shares acquired: 499; reported price per share: $0.00; reported total cash value: $0.
• Shares owned after transaction: Not disclosed in this Form 4.
• Exhibit listed: Exhibit 24 — Power of Attorney.
• No footnotes (e.g., 10b5-1, tax withholding) are shown in the filing.

Context
Awards reported at $0 usually reflect compensation grants (such as restricted stock or director grants) rather than open-market purchases and do not necessarily indicate the insider is buying or selling shares for investment reasons. The filing appears timely (filed two days after the reported acquisition). For retail investors, awards confirm compensation alignment but should be considered alongside other disclosure and company fundamentals.